Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
deals
8
×
detroit blog main
detroit top stories
gene therapy
8
×
indiana blog main
8
×
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
startups
fda
merck
alzheimer's disease
cancer immunotherapy
cell therapy
clinical trials
gilead sciences
medicare
novartis
pfizer
What
bio
8
×
roundup
drug
patients
pfizer’s
amid
bombast
cancer
caught
coronavirus
debate
develop
discussion
drugs
efforts
fda
gene
meso’s
miss
moves
news
pandemic
presidential
promise
response
road
talk
terms
therapy
tuesday’s
vaccine
viewers
acquisitions
ahead
albert
alzheimer’s
approval
aren’t
asco
becker
Language
unset
unknown
Current search:
bio
×
photo
×
" indiana blog main "
×
" gene therapy "
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Midterm Fallout, Alzheimer’s Search, Postpartum Panel
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More